GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » Forward Dividend Yield %

CardioGenics Holdings (CardioGenics Holdings) Forward Dividend Yield % : 0.00% (As of Jun. 08, 2024)


View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings Forward Dividend Yield %?

As of today (2024-06-08), the Forward Annual Dividend Yield of CardioGenics Holdings is 0.00%.

As of today (2024-06-08), the Trailing Annual Dividend Yield of CardioGenics Holdings is 0.00%.

CGNH's Forward Dividend Yield % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.465
* Ranked among companies with meaningful Forward Dividend Yield % only.

CardioGenics Holdings's Dividends per Share for the three months ended in Jan. 2016 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of CardioGenics Holdings's Forward Dividend Yield %

For the Diagnostics & Research subindustry, CardioGenics Holdings's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CardioGenics Holdings's Forward Dividend Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CardioGenics Holdings's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where CardioGenics Holdings's Forward Dividend Yield % falls into.



CardioGenics Holdings Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


CardioGenics Holdings  (OTCPK:CGNH) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


CardioGenics Holdings Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


CardioGenics Holdings (CardioGenics Holdings) Business Description

Traded in Other Exchanges
N/A
Address
6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8
CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines